KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Preferred Shares (2016 - 2020)

Pfizer (PFE) has disclosed Preferred Shares for 12 consecutive years, with $17.0 million as the latest value for Q1 2020.

  • On a quarterly basis, Preferred Shares fell 10.53% to $17.0 million in Q1 2020 year-over-year; TTM through Mar 2020 was $17.0 million, a 10.53% decrease, with the full-year FY2019 number at $17.0 million, down 10.53% from a year prior.
  • Preferred Shares was $17.0 million for Q1 2020 at Pfizer, roughly flat from $17.0 million in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $26.0 million in Q2 2016 to a low of $17.0 million in Q4 2019.
  • A 5-year average of $21.1 million and a median of $21.0 million in 2017 define the central range for Preferred Shares.
  • Peak YoY movement for Preferred Shares: fell 7.14% in 2016, then fell 13.04% in 2018.
  • Pfizer's Preferred Shares stood at $24.0 million in 2016, then dropped by 12.5% to $21.0 million in 2017, then fell by 9.52% to $19.0 million in 2018, then fell by 10.53% to $17.0 million in 2019, then changed by 0.0% to $17.0 million in 2020.
  • Per Business Quant, the three most recent readings for PFE's Preferred Shares are $17.0 million (Q1 2020), $17.0 million (Q4 2019), and $18.0 million (Q3 2019).